Literature DB >> 658124

Comparative pharmacology of the optical isomers of ketamine in mice.

S Ryder, W L Way, A J Trevor.   

Abstract

Relative pharmacological potencies of the optical isomers of ketamine have been estimated in ICR mice. The (+)-isomer was 3X more potent than (-)-ketamine as an analgesic using the phenylquinone writhing test, only 1.5X more potent in terms of hypnotic activity and 1.8X more potent in causing locomotor stimulation. At equianalgesic doses (+)-ketamine caused less stimulation of locomotor activity than the (-)-isomer. These potency differences did not appear to be due to differences in biodisposition although stereoselective metabolism was demonstrated in vivo. Analgesia induced by ketamine was reversed by 10 mg/kg of naloxone.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 658124     DOI: 10.1016/0014-2999(78)90217-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  21 in total

Review 1.  General anaesthetic actions on ligand-gated ion channels.

Authors:  M D Krasowski; N L Harrison
Journal:  Cell Mol Life Sci       Date:  1999-08-15       Impact factor: 9.261

2.  Combining sevoflurane anesthesia with fentanyl-midazolam or s-ketamine in laboratory mice.

Authors:  Nikola Cesarovic; Paulin Jirkof; Andreas Rettich; Flora Nicholls; Margarete Arras
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-03       Impact factor: 1.232

3.  Effects of the noncompetitive N-methyl-d-aspartate receptor antagonists ketamine and MK-801 on pain-stimulated and pain-depressed behaviour in rats.

Authors:  T M Hillhouse; S S Negus
Journal:  Eur J Pain       Date:  2016-02-23       Impact factor: 3.931

4.  The Epidural and Intrathecal Administration of Ketamine.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

Review 5.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

6.  Ketamine anesthesia.

Authors:  J R Werther
Journal:  Anesth Prog       Date:  1985 Sep-Oct

7.  Microglial Ca(2+)-activated K(+) channels are possible molecular targets for the analgesic effects of S-ketamine on neuropathic pain.

Authors:  Yoshinori Hayashi; Kodai Kawaji; Li Sun; Xinwen Zhang; Kiyoshi Koyano; Takeshi Yokoyama; Shinichi Kohsaka; Kazuhide Inoue; Hiroshi Nakanishi
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

8.  Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.

Authors:  Nolan R Williams; Boris D Heifets; Christine Blasey; Keith Sudheimer; Jaspreet Pannu; Heather Pankow; Jessica Hawkins; Justin Birnbaum; David M Lyons; Carolyn I Rodriguez; Alan F Schatzberg
Journal:  Am J Psychiatry       Date:  2018-08-29       Impact factor: 18.112

Review 9.  Ketamine and phencyclidine: the good, the bad and the unexpected.

Authors:  D Lodge; M S Mercier
Journal:  Br J Pharmacol       Date:  2015-07-28       Impact factor: 8.739

10.  Epidural ketamine for postoperative analgesia.

Authors:  M Naguib; Y Adu-Gyamfi; G H Absood; H Farag; H K Gyasi
Journal:  Can Anaesth Soc J       Date:  1986-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.